Clinical Trial Update: A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV) [NA]

View source ↗

Summary

A prospective study evaluating seroprevalence and seroconversion of antibodies against adeno-associated virus (AAV) in Hemophilia A patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Hemophilia A | NA | Status: TERMINATED